GlassScriptPhysician profile
Heather S Kopff
NPI 1568454577
$7,137.29
in general payments reported to CMS, 2019-2025
49 companies · $899 in 2025
The $899 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $948 · 2021: $1,571 · 2022: $1,219 · 2023: $1,152 · 2024: $961 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,011.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,519.83 | 2020-2025 | |
| Novo Nordisk INC | $809.67 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $673.54 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $422.92 | 2021-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $388.82 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $326.72 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $277.56 | 2019-2025 | |
| Amgen INC. | $274.03 | 2019-2025 | Evenity, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $227.71 | 2019-2022 | |
| Lilly USA, LLC | $221.73 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Abbott Laboratories | $205.69 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amarin Pharma, INC. | $196.85 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $145.61 | 2020-2023 | Verquvo, Belsomra, Steglatro |
| E.R. Squibb & Sons, L.L.C. | $97.01 | 2019-2025 | Eliquis |
| Allergan, INC. | $95.97 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Kopff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.